AI-Driven Drug Discovery in Neuropharmacology
This track is dedicated to the application of artificial intelligence and machine learning in drug discovery for neuropharmacology. Researchers are invited to submit abstracts on AI-driven methods for identifying new drug candidates, predicting drug efficacy and safety, and optimizing drug design. The track will cover innovative computational approaches that accelerate the drug discovery process, from target identification to preclinical development. Attendees can expect to learn about the latest tools and technologies that are transforming neuropharmacology, making drug development more efficient and precise.
Related Conference of AI-Driven Drug Discovery in Neuropharmacology
October 29-30, 2026
14th European Congress on Nephrology, Internal Medicine and Kidney Diseases
Paris, France
